Literature DB >> 8006366

Neuroimaging in infantile autism.

T Schifter1, J M Hoffman, H P Hatten, M W Hanson, R E Coleman, G R DeLong.   

Abstract

Metabolic findings using [18F]fluorodeoxyglucose (FDG) with positron emission tomography (PET) and correlative anatomic findings with computed tomography (CT) or magnetic resonance imaging (MRI) were characterized in 13 children with infantile autism. Four of 13 patients had both an abnormal FDG-PET and an abnormal MRI, whereas seven of 13 patients had both a normal FDG-PET and a normal CT or MRI. Sixteen of a total of 195 brain areas qualitatively examined with FDG-PET had a hypometabolic abnormality on PET. Three of the five abnormal structural imaging studies revealed neuronal migrational anomalies (focal pachygyria). In two of the five patients with anatomic abnormalities, these were noted only after knowledge of the FDG-PET findings. Our experience reveals that anatomic and metabolic abnormalities can be found in children who exhibit autistic behavior. An FDG-PET study may provide evidence of metabolic dysfunction after an initially unremarkable MRI scan because subtle anatomic abnormalities (as those seen with neuronal migrational anomalies) may be found only after knowledge of a regional metabolic abnormality.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006366     DOI: 10.1177/088307389400900210

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

1.  Prevalence and Characteristics of Sensory Processing Abnormalities and its Correlation with FDG-PET Findings in Children with Autism.

Authors:  Razia Adam Kadwa; Jitendra Kumar Sahu; Pratibha Singhi; Prahbhjot Malhi; B R Mittal
Journal:  Indian J Pediatr       Date:  2019-10-15       Impact factor: 1.967

2.  The puzzle of autism: an ophthalmologic contribution.

Authors:  M T Miller; K Strömland; C Gillberg; M Johansson; E W Nilsson
Journal:  Trans Am Ophthalmol Soc       Date:  1998

3.  Loss of neurexin-1 in Drosophila melanogaster results in altered energy metabolism and increased seizure susceptibility.

Authors:  Kyra A Levy; Eliana D Weisz; Thomas A Jongens
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

Review 4.  Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review.

Authors:  Zhiqiang Tan; Huiyi Wei; Xiubao Song; Wangxiang Mai; Jiajian Yan; Weijian Ye; Xueying Ling; Lu Hou; Shaojuan Zhang; Sen Yan; Hao Xu; Lu Wang
Journal:  Front Neurosci       Date:  2022-04-13       Impact factor: 5.152

5.  A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.

Authors:  David A Geier; Janet K Kern; Georgia Davis; Paul G King; James B Adams; John L Young; Mark R Geier
Journal:  Med Sci Monit       Date:  2011-06

6.  MRI findings in 77 children with non-syndromic autistic disorder.

Authors:  Nathalie Boddaert; Mônica Zilbovicius; Anne Philipe; Laurence Robel; Marie Bourgeois; Catherine Barthélemy; David Seidenwurm; Isabelle Meresse; Laurence Laurier; Isabelle Desguerre; Nadia Bahi-Buisson; Francis Brunelle; Arnold Munnich; Yves Samson; Marie-Christine Mouren; Nadia Chabane
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

7.  Role of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders.

Authors:  Musthafa Mohamed Essa; Selvaraju Subash; Nady Braidy; Samir Al-Adawi; Chai K Lim; Tamilarasan Manivasagam; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2013-07-21

8.  Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.

Authors:  Alok Sharma; Nandini Gokulchandran; Hemangi Sane; Anjana Nagrajan; Amruta Paranjape; Pooja Kulkarni; Akshata Shetty; Priti Mishra; Mrudula Kali; Hema Biju; Prerna Badhe
Journal:  Stem Cells Int       Date:  2013-08-25       Impact factor: 5.443

Review 9.  Toward a Better Understanding of Neuronal Migration Deficits in Autism Spectrum Disorders.

Authors:  Yi-Hsuan Pan; Nan Wu; Xiao-Bing Yuan
Journal:  Front Cell Dev Biol       Date:  2019-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.